PROTEOME SCIENCES PLCPROTEOME SCIENCES PLCPROTEOME SCIENCES PLC

PROTEOME SCIENCES PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪8.12 M‬GBP
−0.02GBP
‪−2.44 M‬GBP
‪5.03 M‬GBP
‪287.37 M‬
Beta (1Y)
0.70

About PROTEOME SCIENCES PLC


CEO
Mariola Söhngen
Headquarters
Cobham
Founded
1993
ISIN
GB0003104196
FIGI
BBG00MJH1MJ3
Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Cobham, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange PROTEOME SCIENCES PLC stocks are traded under the ticker PRML.
PRML reached its all-time high on May 7, 2021 with the price of 9.10 GBX, and its all-time low was 3.00 GBX and was reached on Oct 10, 2024. View more price dynamics on PRML chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PROTEOME SCIENCES PLC financials in yearly and quarterly reports right on TradingView.
PROTEOME SCIENCES PLC is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PRML net income for the last half-year is ‪−2.21 M‬ GBP, while the previous report showed ‪−1.86 M‬ GBP of net income which accounts for −18.66% change. Track more PROTEOME SCIENCES PLC financial stats to get the full picture.
No, PRML doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROTEOME SCIENCES PLC EBITDA is ‪−2.54 M‬ GBP, and current EBITDA margin is −19.61%. See more stats in PROTEOME SCIENCES PLC financial statements.
Like other stocks, PRML shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTEOME SCIENCES PLC stock right from TradingView charts — choose your broker and connect to your account.